Pfizer Inc (PFE)
26.02
-0.70
(-2.62%)
USD |
NYSE |
Nov 14, 16:00
25.85
-0.17
(-0.65%)
After-Hours: 20:00
Pfizer Net Income (TTM): 4.252B for Sept. 30, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 4.252B |
| June 30, 2024 | -2.595B |
| March 31, 2024 | -309.00M |
| December 31, 2023 | 2.119B |
| September 30, 2023 | 10.48B |
| June 30, 2023 | 21.47B |
| March 31, 2023 | 29.05B |
| December 31, 2022 | 31.37B |
| September 30, 2022 | 29.77B |
| June 30, 2022 | 29.31B |
| March 31, 2022 | 24.97B |
| December 31, 2021 | 21.98B |
| September 30, 2021 | 19.43B |
| June 30, 2021 | 12.76B |
| March 31, 2021 | 10.68B |
| December 31, 2020 | 9.159B |
| September 30, 2020 | 7.73B |
| June 30, 2020 | 13.94B |
| March 31, 2020 | 15.50B |
| December 31, 2019 | 16.03B |
| September 30, 2019 | 16.22B |
| June 30, 2019 | 12.65B |
| March 31, 2019 | 11.48B |
| December 31, 2018 | 11.15B |
| September 30, 2018 | 23.82B |
| Date | Value |
|---|---|
| June 30, 2018 | 22.55B |
| March 31, 2018 | 21.75B |
| December 31, 2017 | 21.31B |
| September 30, 2017 | 9.809B |
| June 30, 2017 | 8.324B |
| March 31, 2017 | 7.298B |
| December 31, 2016 | 7.215B |
| September 30, 2016 | 6.268B |
| June 30, 2016 | 7.043B |
| March 31, 2016 | 7.622B |
| December 31, 2015 | 6.96B |
| September 30, 2015 | 8.36B |
| June 30, 2015 | 8.896B |
| March 31, 2015 | 9.182B |
| December 31, 2014 | 9.135B |
| September 30, 2014 | 10.48B |
| June 30, 2014 | 10.40B |
| March 31, 2014 | 21.58B |
| December 31, 2013 | 22.00B |
| September 30, 2013 | 25.75B |
| June 30, 2013 | 26.37B |
| March 31, 2013 | 15.53B |
| December 31, 2012 | 14.57B |
| September 30, 2012 | 9.694B |
| June 30, 2012 | 10.22B |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-2.595B
Minimum
Jun 2024
31.37B
Maximum
Dec 2022
15.35B
Average
14.72B
Median
Net Income (TTM) Benchmarks
| Amgen Inc | 4.23B |
| Johnson & Johnson | 14.68B |
| Eli Lilly and Co | 8.370B |
| Merck & Co Inc | 12.15B |
| Moderna Inc | -2.224B |